Platelet Rich Plasma (PRP) Bio Stimulant Gel Dressing in Treating Chronic Non Healing Leg and Foot Ulcers: Cost and Effectiveness

Sponsor
Zagazig University (Other)
Overall Status
Completed
CT.gov ID
NCT04065594
Collaborator
(none)
44
1
2
22
2

Study Details

Study Description

Brief Summary

Background

Chronic non-healing ulcer is a common problem met in clinical practice and represents a burden to the patients. Chronic ulcer lacks growth factors (GFs) to promote the healing process and is frequently followed by superadded infections. Ordinary technique such as wound debridement and regular dressings cannot provide adequate results as these techniques cannot provide the necessary GFs. Platelet-rich plasma (PRP) helps wound healing by releasing various types of GFs.

The aim: to evaluate and compare the efficacy of PRP dressing versus traditional dressings in the treatment of chronic non-healing leg and foot ulcers of different etiology as regard cost of overall treatment and effectiveness (reduction of the size of the ulcer and safety of the technique).

Methods

This prospective study was performed on inpatients and outpatients in general surgery department, Zagazig university hospital from June 2017 to January 2019. Patients were divided randomly into two groups: group A received PRP dressing (N=22, 50%) and group B received conventional ordinary dressing (N=22, 50%).The mean follow-up period was 3 months after the last dressing. Patients treated with PRP at once-weekly interval for a maximum of 12 dressings while patients with ordinary dressings may need one dressing every other day for a maximum of 12 weeks. The reduction in the size of the ulcers (area and volume) in both groups was assessed using centimeter scale and Digital photographs before and after each session and during follow up period.

Keywords: Platelet-rich plasma, ulcers, non-healing, ordinary dressing.

Condition or Disease Intervention/Treatment Phase
  • Procedure: PRP dressing
  • Procedure: conventional ordinary dressing
N/A

Detailed Description

Chronic non-healing ulcer is a common problem met in clinical practice and represents a burden to the patients. Chronic ulcer lacks growth factors (GFs) to promote the healing process and is frequently followed by superadded infections. Ordinary technique such as wound debridement and regular dressings cannot provide adequate results as these techniques cannot provide the necessary GFs. Platelet-rich plasma (PRP) helps wound healing by releasing various types of GFs.

The aim: to evaluate and compare the efficacy of PRP dressing versus traditional dressings in the treatment of chronic non-healing leg and foot ulcers of different etiology as regard cost of overall treatment and effectiveness (reduction of the size of the ulcer and safety of the technique).

Methods

This prospective study was performed on inpatients and outpatients in general surgery department, Zagazig university hospital from June 2017 to January 2019. Patients were divided randomly into two groups: group A received PRP dressing (N=22, 50%) and group B received conventional ordinary dressing (N=22, 50%).The mean follow-up period was 3 months after the last dressing. Patients treated with PRP at once-weekly interval for a maximum of 12 dressings while patients with ordinary dressings may need one dressing every other day for a maximum of 12 weeks. The reduction in the size of the ulcers (area and volume) in both groups was assessed using centimeter scale and Digital photographs before and after each session and during follow up period.

Keywords: Platelet-rich plasma, ulcers, non-healing, ordinary dressing.

Study Design

Study Type:
Interventional
Actual Enrollment :
44 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Platelet Rich Plasma (PRP) Bio Stimulant Gel Dressing in Treating Chronic Non Healing Leg and Foot Ulcers: Cost and Effectiveness
Actual Study Start Date :
Jun 1, 2017
Actual Primary Completion Date :
Jan 1, 2019
Actual Study Completion Date :
Apr 1, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: PRP dressing

Procedure: PRP dressing
PRP dressing gel dressings for treatment of chronic ulcer

Experimental: conventional ordinary dressing

Procedure: conventional ordinary dressing
conventional ordinary dressing for treatment of chronic ulcer

Outcome Measures

Primary Outcome Measures

  1. change the ulcer size [1.8 years]

    healing of the ulcer is assessed using centimeter scale before each dressing

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • 18-80 years old,

  • males and non-pregnant females,

  • hemoglobin (> 10 gm. /dL),

  • post-prandial blood sugar ≤ 140 mg% if diabetic,

  • Wounds free of infection (sterile swab) or necrosis.

Exclusion Criteria:
  • malignant ulcer(by biopsy),

  • pus discharge/slough,

  • ulcer with exposed tendons/ligaments/bone,

  • ischemic ulcer (by duplex U/S),

  • non-compliant patients ,

  • radiation near to the site of ulcer,

  • osteomyelitis of underlying bone (x-ray-bone scan) ,

  • steroids therapy ,

  • thrombocytopenia(< 150,000/dl)

  • patients unfit or refuse blood donation from himself or from others.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Tamer Alsaied Alnaimy Zagazig Sharkia Egypt 055

Sponsors and Collaborators

  • Zagazig University

Investigators

  • Study Director: tamer A Alnaimy, MD, faculty of medicine Zagazig university

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Tamer Alsaied Alnaimy, clinical professour, Zagazig University
ClinicalTrials.gov Identifier:
NCT04065594
Other Study ID Numbers:
  • zagazig university 1
First Posted:
Aug 22, 2019
Last Update Posted:
Aug 22, 2019
Last Verified:
Aug 1, 2019
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Tamer Alsaied Alnaimy, clinical professour, Zagazig University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 22, 2019